Long non-coding RNAs as potential therapeutic targets in human breast cancer

A panel of nine human cancer cell lines, i.e., MCF-7 (breast), NCI/ADR-RES (ovarian cancer with a phenotype of multiple-drug resistance), UACC-62 (melanoma), NCI- H460 (non-small

Lectin binding properties of human breast cancer cell lines and human milk with particular reference for helix

The cytotoxicity assays were performed using the tumor cell lineages UACC-62 (human melanoma), MCF-7 (human breast cancer) and TK-10 (human renal cancer).. The cell lineages were

The organic crude extracts, phases and compounds assays were performed using the tumor cell lines UACC-62 (human melanoma cancer), MCF-7 (human breast cancer) and

We compared the proliferation of the human breast cancer cell line MDA-MB-231 and of the non-cancer human mammary epithelial cell line MCF-10A in different experimental

MCF-7 (Human breast cancer cell line), SGC7901 (human gastric carcinoma cell line), LS-174T (human colon adenocarcinoma cell line) and A549 (human lung adenocarcinoma cell)

Lupeportlandol acetate was inactive in cytotoxicity assays in vitro against three human tumor cell lines: MCF-7 (breast cancer), NCI-H460 (non-small cell lung cancer) and SF-268

Antitumor activity assays of the new complexes using the invasive MDA-MB-231 and non-invasive MCF-7 human breast tumor cell lines indicated a good degree of cytotoxicity for